102 related articles for article (PubMed ID: 11712467)
41. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
42. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
Schulz HU; Schürer M; Bässler D; Weiser D
Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
[TBL] [Abstract][Full Text] [Related]
43. St. John's Wort: more implications for cancer patients.
Mansky PJ; Straus SE
J Natl Cancer Inst; 2002 Aug; 94(16):1187-8. PubMed ID: 12189216
[No Abstract] [Full Text] [Related]
44. 2.1 A crystal structure of human PXR in complex with the St. John's wort compound hyperforin.
Watkins RE; Maglich JM; Moore LB; Wisely GB; Noble SM; Davis-Searles PR; Lambert MH; Kliewer SA; Redinbo MR
Biochemistry; 2003 Feb; 42(6):1430-8. PubMed ID: 12578355
[TBL] [Abstract][Full Text] [Related]
45. Effect of simultaneous induction and inhibition of CYP3A by St John's Wort and ritonavir on CYP3A activity.
Hafner V; Jäger M; Matthée AK; Ding R; Burhenne J; Haefeli WE; Mikus G
Clin Pharmacol Ther; 2010 Feb; 87(2):191-6. PubMed ID: 19924124
[TBL] [Abstract][Full Text] [Related]
46. Bioactive constituent production in St. John's Wort in vitro hairy roots. Regenerated plant lines.
Bertoli A; Giovannini A; Ruffoni B; Guardo AD; Spinelli G; Mazzetti M; Pistelli L
J Agric Food Chem; 2008 Jul; 56(13):5078-82. PubMed ID: 18553917
[TBL] [Abstract][Full Text] [Related]
47. Differential accumulation of hyperforin and secohyperforin in Hypericum perforatum tissue cultures.
Charchoglyan A; Abrahamyan A; Fujii I; Boubakir Z; Gulder TA; Kutchan TM; Vardapetyan H; Bringmann G; Ebizuka Y; Beerhues L
Phytochemistry; 2007 Nov; 68(21):2670-7. PubMed ID: 17643455
[TBL] [Abstract][Full Text] [Related]
48. The production of hypericins and hyperforin by in vitro cultures of St. John's wort (Hypericum perforatum).
Kirakosyan A; Sirvent TM; Gibson DM; Kaufman PB
Biotechnol Appl Biochem; 2004 Feb; 39(Pt 1):71-81. PubMed ID: 14521510
[TBL] [Abstract][Full Text] [Related]
49. Hyperforin.
Beerhues L
Phytochemistry; 2006 Oct; 67(20):2201-7. PubMed ID: 16973193
[TBL] [Abstract][Full Text] [Related]
50. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
Dimpfel W; Schober F; Mannel M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945
[TBL] [Abstract][Full Text] [Related]
51. First-episode psychosis after taking an extract of Hypericum perforatum (St John's Wort).
Shimizu K; Nakamura M; Isse K; Nathan PJ
Hum Psychopharmacol; 2004 Jun; 19(4):275-6. PubMed ID: 15181657
[No Abstract] [Full Text] [Related]
52. Instability of St. John's wort (Hypericum perforatum L.) and degradation of hyperforin in aqueous solutions and functional beverage.
Ang CY; Hu L; Heinze TM; Cui Y; Freeman JP; Kozak K; Luo W; Liu FF; Mattia A; DiNovi M
J Agric Food Chem; 2004 Oct; 52(20):6156-64. PubMed ID: 15453681
[TBL] [Abstract][Full Text] [Related]
53. Mass spectral characterization of phloroglucinol derivatives hyperforin and adhyperforin.
Sleno L; Daneshfar R; Eckert GP; Müller WE; Volmer DA
Rapid Commun Mass Spectrom; 2006; 20(18):2641-8. PubMed ID: 16912989
[TBL] [Abstract][Full Text] [Related]
54. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.
Komoroski BJ; Zhang S; Cai H; Hutzler JM; Frye R; Tracy TS; Strom SC; Lehmann T; Ang CY; Cui YY; Venkataramanan R
Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173
[TBL] [Abstract][Full Text] [Related]
55. St. John's Wort seed and feverfew flower extracts relieve painful diabetic neuropathy in a rat model of diabetes.
Galeotti N; Maidecchi A; Mattoli L; Burico M; Ghelardini C
Fitoterapia; 2014 Jan; 92():23-33. PubMed ID: 24125916
[TBL] [Abstract][Full Text] [Related]
56. Fast high-performance liquid chromatographic analysis of naphthodianthrones and phloroglucinols from Hypericum perforatum extracts.
Tolonen A; Hohtola A; Jalonen J
Phytochem Anal; 2003; 14(5):306-9. PubMed ID: 14516003
[TBL] [Abstract][Full Text] [Related]
57. St John's wort and depression: slight efficacy at best, many drug interactions.
Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702
[TBL] [Abstract][Full Text] [Related]
58. Enrichment of hyperforin from St. John's wort (Hypericum perforatum) by pilot-scale supercritical carbon dioxide extraction.
Römpp H; Seger C; Kaiser CS; Haslinger E; Schmidt PC
Eur J Pharm Sci; 2004 Mar; 21(4):443-51. PubMed ID: 14998574
[TBL] [Abstract][Full Text] [Related]
59. Hyperforin content determines the magnitude of the St John's wort-cyclosporine drug interaction.
Mai I; Bauer S; Perloff ES; Johne A; Uehleke B; Frank B; Budde K; Roots I
Clin Pharmacol Ther; 2004 Oct; 76(4):330-40. PubMed ID: 15470332
[TBL] [Abstract][Full Text] [Related]
60. Safety of St John's wort (Hypericum perforatum).
Jobst KA; McIntyre M; St George D; Whitelegg M
Lancet; 2000 Feb; 355(9203):575. PubMed ID: 10683027
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
